Global Brain Tumor Therapeutics Market: Poor Survival Scope Necessitates Advances in Novel Drug Development Ventures
Surged prevalence of brain tumors often resulting in fatality amongst adult and pediatric cases alike have bolstered substantial advances in global brain tumor therapeutics market. Several biopharmaceutical entities are akin on striking novel deals to attain new drugs that render promising outcome in arresting frequent prevalence. High rates of brain tumor recurrence due to blood brain barrier, triggers recurrence, thereby diminishing survival ratios and quality of life. These pertinent market highlights are in accordance with Market Research Hub's (MRH) recent...
View full press release